Skip to main content

Advertisement

SpringerLink
Log in

Genotoxicity and carcinogenicity studies of antihistamines

  • Review Article
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

This review provides a compendium of the results of genotoxicity and carcinogenicity assays performed on marketed antihistamines. Of the 70 drugs examined, 29 (41.4%) have at least one genotoxicity and/or carcinogenicity test result: 12 tested positive in at least one genotoxicity assay, six in at least one carcinogenicity assay, and four gave a positive response in both at least one genotoxicity assay and at least one carcinogenicity assay. Of 19 drugs with both genotoxicity and carcinogenicity data, eight were neither genotoxic nor carcinogenic, two were carcinogenic in at least one sex of mice or rats but tested negative in genotoxicity assays, five tested positive in at least one genotoxicity assay but were non-carcinogenic, and four gave a positive response in at least one genotoxicity assay and in at least one carcinogenicity assay. Only 12 (17.1%) of the 70 drugs examined have all data required by present guidelines for testing of pharmaceuticals, but it should be considered that a large fraction of them were developed and marketed prior the present regulatory climate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Althaus FR, Lawrence SD, Sattler GL, Pitot HC (1982) DNA damage induced by the antihistaminic drug methapyrilene hydrochloride. Mutat Res 103:213–218

    Article  PubMed  CAS  Google Scholar 

  • Anderson BE, Zeiger E, Shelby MD, Resnick MA, Gaulati DK, Ivett JL, Loveday KS (1990) Chromosome aberration and sister chromatid exchange test results with 42 chemicals. Environ Mol Mutagen 16(suppl 18):55–137

    Article  PubMed  CAS  Google Scholar 

  • Andrews AW, Lijinsky W, Snyder SW (1984) Mutagenicity of amine drugs and their products of nitrosation. Mutat Res 135:105–108

    Article  PubMed  CAS  Google Scholar 

  • Ashby J, Callander RD, Paton D, Zeiger E, Ratpan F (1988) Weak and unexpected mutagenicity to Salmonella of the rat hepatocarcinogen methapyrilene. Environ Mol Mutagen 12:243–252

    PubMed  CAS  Google Scholar 

  • Benze J, Gypen L, Vanderberghe J, Lampo A, De Coster R, Bowden C, Van Cauteren H (1995) Carcinogenicity studies of astemizole in mice and rats. Cancer Res 55:5589–5594

    PubMed  CAS  Google Scholar 

  • Brambilla G, Martelli A (2007) Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products. Mutat Res 635:17–52

    Article  PubMed  CAS  Google Scholar 

  • Budroe JD, Shaddock JG, Casciano DA (1984) A study of the potential genotoxicity of methapyrilene and related antihistamines using the hepatocyte/DNA repair assay. Mutat Res 135:131–137

    Article  PubMed  CAS  Google Scholar 

  • Casciano DA, Schol HM (1984) Methapyrilene is inactive in the hepatocyte-mediated Chinese hamster ovary/hypoxanthine-guanine phosphoribosyl transferase mutational assay. Cancer Lett 21:337–341

    Article  PubMed  CAS  Google Scholar 

  • Casciano DA, Talaska G, Clive D (1991) The potent carcinogen methapyrilene induces mutations in the L5178Y mouse lymphoma cells in the apparent absence of DNA adduct formation. Mutat Res 263:127–132

    Article  PubMed  CAS  Google Scholar 

  • Council Directive 65/65/EEC of the European Economic Community of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (1965)

  • Fujioka Y, Maizumi H (1983) Further studies on mutagenicity of chlorpromazine and promethazine. Shigaku 71:141–142

    CAS  Google Scholar 

  • Galloway SM, Armstrong MJ, Reuben C, Colman S, Brown B, Cannon C, Bloom AD, Nakamura F, Ahmed M, Duk S, Rimpo J, Margolin BH, Resnick MA, Anderson B, Zeiger E (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environ Mol Mutagen 10(suppl 10):1–175

    Article  PubMed  CAS  Google Scholar 

  • Gibson JP, Huffmann KW, Newberne JW (1982) Preclinical safety studies with terfenadine. Arzneim-Forsch 32:1179–1184

    CAS  Google Scholar 

  • Gocke E (1996) Review of the genotoxic properties of chlorpromazine and related phenothiazines. Mutat Res 366:9–21

    PubMed  Google Scholar 

  • Greenman DL, Allen R, Dahlgren R, Cronin GM, Allaben WT (1995a) Chronic toxicity/carcinogenicity study of pyrilamine in B6C3F1 mice. J Am Coll Toxicol 14:148–157

    CAS  Google Scholar 

  • Greenman DL, Cronin GM, Dahlgren R, Allen R, Allaben W (1995b) Chronic feeding study of pyrilamine in fisher 344 rats. Fundam Appl Toxicol 25:1–8

    Article  PubMed  CAS  Google Scholar 

  • Greenman DL, Sheldon W, Schieferstein G, Allen R, Allaben WT (1995c) Chronic study of triprolidine for oncogenicity in mice. Fundam Appl Toxicol 25:138–145

    Article  PubMed  CAS  Google Scholar 

  • Greenman DL, Sheldon W, Schieferstein G, Allen R, Allaben WT (1995d) Triprolidine: 104-week feeding study in rats. Fundam Appl Toxicol 27:223–231

    Article  PubMed  CAS  Google Scholar 

  • Habs M, Shubik P, Eisenbrand G (1986) Carcinogenicity of methapyrilene hydrochloride, mepyramine hydrochloride, thenyldiamine hydrochloride, and pyribenzamine hydrochloride in Sprague-Dawley rats. J Cancer Res Clin Oncol 111:71–74

    Article  PubMed  CAS  Google Scholar 

  • Hansen EB, Cerniglia CE, Korfmacher WA, Miller DW, Heflich RH (1987) Microbial transformation of the antihistamine pyrilamine maleate. Formation of potential mammalian metabolites. Drug Metab Dispos 15:97–106

    PubMed  CAS  Google Scholar 

  • Hensen EB Jr, Heflich RH, Korfmacher WA, Miller DW (1988) Microbial transformation of the antihistaminic drug triprolidine hydrochloride. J Pharm Sci 77:259–264

    Article  Google Scholar 

  • Hite M, Algon J, Peck HM (1977) The effect of cyproheptadine on the chromosomes of human lymphocytes in vitro. Arzneim-Fosch 27:1203–1206

    CAS  Google Scholar 

  • International Agency for Research on Cancer (1972–2007) IARC monographs on the evaluation of carcinogenic risks to humans, vol 1–91. IARC, Lyon

  • International Agency for Research on Cancer (1987) IARC monographs on the evaluation of carcinogenic risks to humans, supplement 7, overall evaluation of carcinogenicity: an updating of IARC monographs, vol 1–42. IARC, Lyon, France

  • International Agency for Research on Cancer (2001) IARC monographs on the evaluation of carcinogenic risks to humans, vol 79, some thyrotropic agents. IARC, Lyon, France, pp 145–159

  • Ishidate M Jr, Harnois MC, Sofuni T (1988) A comprehensive analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat Res 195:151–213

    PubMed  CAS  Google Scholar 

  • Iwase Y, Uno Y, Ohkouchi A, Molinier B, Simonnard A, Lebrun C, Moysan F (1998) Mutagenicity and clastogenicity studies with mizolastine. Yakuri to Chiryo 26 (suppl 4):663–672

  • Iype PT, Ray-Chaudhuri R, Lijinsky W, Kelley SP (1982) Inability of methapyrilene to induce sister chromatid exchanges in vitro and in vivo. Cancer Res 42:4614–4618

    PubMed  CAS  Google Scholar 

  • Jackson CD, Blackwell BN (1993) Two-year toxicity study of doxylamine succinate in the fisher 344 rat. J Am Coll Toxicol 12:1–11

    CAS  Google Scholar 

  • Jackson CD, Sheldon W (1993) Two-year toxicity study of doxylamine succinate in B6C3F1 mice. J Am Coll Toxicol 12:311–321

    CAS  Google Scholar 

  • Kirkland D, Speit G (2008) Evaluation of the ability of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. III. Appropriate follow-up testing in vivo. Mutat Res 654:114–132

    PubMed  CAS  Google Scholar 

  • Kirkland DJ, Aardema M, Henderson L, Muller L (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat Res 584:1–256

    PubMed  CAS  Google Scholar 

  • Kirkland DJ, Hayashi M, Jacobson-Kram D, Kasper P, MacGregor JT, Muller L, Uno Y (2007) Summary of major conclusions from the 4th IWGT, San Francisco, 9–10 September 2005. Mutat Res 627:5–9

    PubMed  CAS  Google Scholar 

  • Kubinski H, Gutzke GE, Kubinski ZO (1981) DNA-cell-binding (DCB) assay for suspected carcinogens and mutagens. Mutat Res 89:95–136

    Article  PubMed  CAS  Google Scholar 

  • Lijinsky W (1984a) Induction of tumours in rats by feeding nitrosatable amines together with sodium nitrite. Food Chem Toxicol 22:715–720

    Article  PubMed  CAS  Google Scholar 

  • Lijinsky W (1984b) Chronic toxicity tests of pyrilamine maleate and methapyrilene hydrochloride in F344 rats. Food Chem Toxicol 22:27–30

    Article  PubMed  CAS  Google Scholar 

  • Lijinsky W, Yamashita K (1988) Lack of binding of methapyrilene and similar antihistamines to rat liver DNA examined by 32P-postlabeling. Cancer Res 48:6475–6477

    PubMed  CAS  Google Scholar 

  • Loveday KS, Lugo MH, Resnick MA, Anderson BE, Zeiger E (1989) Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro: II. Results with 20 chemicals. Environ Mol Mutagen 13:60–94

    Article  PubMed  CAS  Google Scholar 

  • Madle S, Dean SW, Andrae U, Brambilla G, Burlinson B, Doolittle DJ, Furihata C, Hertner T, McQueen CA, Mori H (1994) Recommendations for the performance of UDS tests in vitro and in vivo. Mutat Res 312:263–285

    PubMed  CAS  Google Scholar 

  • Martelli A, Cajelli E, Pino A, Robbiano L, Brambilla G (1984) DNA damage and repair induced in rat hepatocytes primary cultures by five antihistamines and their nitrosation products. ICRS Med Sci 12:1054–1055

    CAS  Google Scholar 

  • Martindale (2007) The complete drug reference, 35th edn. Pharmaceutical Press, London, pp 1–116

    Google Scholar 

  • Mavournin KH, Blakey DH, Cimino MC, Salamone MF, Heddle JH (1990) The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. environmental protection agency gene-tox program. Mutat Res 239:29–80

    PubMed  CAS  Google Scholar 

  • McGregor DB, Brown AG, Howgate S, McBride D, Riach C, Caspary WJ (1991) Responses of the L5178Y mouse lymphoma cell forward mutation assay. V: 27 coded chemicals. Environ Mol Mutagen 17:196–219

    Article  PubMed  CAS  Google Scholar 

  • Mirsalis JC (1987) Genotoxicity, toxicity, and carcinogenicity of the antihistamine methapyrilene. Mutat Res 185:309–317

    PubMed  CAS  Google Scholar 

  • Mortelmans K, Haworth S, Lawlor T, Speck K, Tainer B, Zeiger E (1986) Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ Mutagen 8 (suppl 7):1–119

    Google Scholar 

  • Motohashi N, Kurihara T, Kawase M, Hever A, Tanaka M, Szabo A, Nacsa J, Yamanaka W, Kerim A, Molnar J (1997) Drug resistance reversal, anti-mutagenicity and antiretroviral effect of phthalimido and chloroethyl-phenothiazines. Anticancer Res 17:3537–3543

    PubMed  CAS  Google Scholar 

  • Müller L, Korta A, Madle S (1989) Mutagenicity testing of doxylamine succinate, an antinauseant drug. Toxicol Lett 49:79–86

    Article  PubMed  Google Scholar 

  • Müller L, Kikuchi Y, Probst G, Schechtman L, Shimada H, Sofuni T, Tweats D (1999) ICH-harmonized guidance on genotoxicity testing of pharmaceuticals; evolution, reasoning and impact. Mutat Res 436:195–225

    Article  PubMed  Google Scholar 

  • National Toxicology Program (1986) Toxicology and carcinogenesis studies of chlorpheniramine maleate (CAS No. 113-928) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 317

  • National Toxicology Program (1989) Toxicology and carcinogenesis studies of diphenhydramine hydrochloride (CAS No. 147-24-0) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser 355

  • National Toxicology Program (1993) Technical report series, toxicology and carcinogenesis studies of promethazine hydrochloride (CAS No. 58-33-3) in F344/N rats and B6C3F1 mice (Gavage studies), No. TR-425

  • NCI/NTP Carcinogenesis Technical Report Series (1999) National cancer institute/national toxicology program; US Department of Health and Human Services, TR-485

  • Oberly TJ, Bewsey BJ, Probst GS (1984) An evaluation of the L5178Y TK ± mouse lymphoma forward mutation assay using 42 chemicals. Mutat Res 125:291–306

    Article  PubMed  CAS  Google Scholar 

  • Oberly TJ, Scheuring JC, Richardson KA, Richardson FC, Garriot ML (1993) The evaluation of methapyrilene for bacterial mutation with metabolic activation by Aroclor-induced, methapyrilene-induced and noninduced rat-liver S9. Mutat Res 299:77–84

    Article  PubMed  CAS  Google Scholar 

  • Physicians (2005) Desk reference, 59th edn. Thomson PDR, Montvale

  • Probst GS, Neal SB (1980) The induction of unscheduled DNA synthesis by antihistamines in primary hepatocyte cultures. Cance Lett 10:67–73

    Article  CAS  Google Scholar 

  • Robbiano L, Gazzaniga GM, Martelli A, Pino A, Brambilla G (1986) DNA-damaging activity of tripelennamine in primary cultures of human hepatocytes. Mutat Res 173:229–232

    Article  PubMed  CAS  Google Scholar 

  • Snyder RD (1998) A review and investigation into the mechanistic basis of the genotoxicity of antihistamines. Mutat Res 411:235–248

    Article  PubMed  CAS  Google Scholar 

  • Snyder RD, Green JW (2001) A review of the genotoxicity of marketed pharmaceuticals. Mutat Res 488:151–169

    Article  PubMed  CAS  Google Scholar 

  • Snyder RD, Ewing D, Hendry LB (2006) DNA intercalative potential of marketed drugs testing positive in in vitro assays. Mutat Res 609:47–59

    PubMed  CAS  Google Scholar 

  • Storer RD, McKelvey TW, Kraynak AR, Elia MC, Barnum JE, Harmon LS, Nichols WW, De Luca JG (1996) Revalidation of the in vitro alkaline elution/rat hepatocyte assay for DNA damage: improved criteria for assessment of cytotoxicity and genotoxicity and results for 81 compounds. Mutat Res 368:59–101

    Article  PubMed  CAS  Google Scholar 

  • Tennant RW, Margolin BH, Shelby MD, Zeiger E, Haseman JK, Spalding J, Caspary W, Resnick M, Stasiewicz S, Anderson B, Minor R (1987) Prediction of chemical carcinogenesis in rodents from in vitro genetic toxicity assays. Science 236:933–941

    Article  PubMed  CAS  Google Scholar 

  • Thybaud V, Aardema M, Clements J, Dearfield K, Galloway S, Hayashi M, Jacobson-Kram D, Kirkland D, MacGregor JT, Marzin D, Ohyama W, Schuler M, Suzuki H, Zeiger E (2007) Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. Mutat Res 627:41–58

    PubMed  CAS  Google Scholar 

  • Tucker JD, Auletta A, Cimino MC, Dearfield KL, Jacobson-Kram D, Tice RR, Carrano AV (1993) Sister chromatid exchange: second report of the Gene-Tox Program. Mutat Res 297:101–180

    PubMed  CAS  Google Scholar 

  • Turner NT, Woolley JL Jr, Hozier JC, Sawyer JR, Clive D (1987) Methapyrilene is a genotoxic carcinogen. Studies on methapyrilene and pyrilamine in the L5178Y/TK ± mouse lymphoma assay. Mutat Res 189:285–297

    Article  PubMed  CAS  Google Scholar 

  • Tweats DJ, Blakey D, Heflich RH, Jacobs A, Jacobsen SD, Morita T, Nohmi T, O’Donovan MR, Sasaki YF, Sofuni T, Tice R (2007) Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests. I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. Mutat Res 627:78–91

    PubMed  CAS  Google Scholar 

  • US Department of Health and Human Sciences (1988) Registry of toxic effects of chemical substances, 1985–1986. Washington

  • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1996) Guideline for industry. S2A. Specific aspects of regulatory genotoxicity tests for pharmaceuticals

  • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1996) Guidelines for industry. S1A. The need for long-term rodent carcinogenicity studies of pharmaceuticals

  • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1997) Guidance for industry. S2B. Genotoxicity: a standard battery for genotoxicity testing of pharmaceuticals

  • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (1997) Guidance for industry. S1B. Testing for carcinogenicity of pharmaceuticals

  • Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W (1987) Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ Mol Mutagen 9(suppl 9):1–110

    CAS  Google Scholar 

  • Zeiger E, Haseman JK, Shelby MD, Margolin BH, Tennant RW (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ Mol Mutagen 16(suppl 18):1–14

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Clinical Pharmacology and Toxicology, University of Genoa, Viale Benedetto XV 2, 16132, Genoa, Italy

    Giovanni Brambilla, Francesca Mattioli, Luigi Robbiano & Antonietta Martelli

Authors
  1. Giovanni Brambilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesca Mattioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luigi Robbiano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonietta Martelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Brambilla.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brambilla, G., Mattioli, F., Robbiano, L. et al. Genotoxicity and carcinogenicity studies of antihistamines. Arch Toxicol 85, 1173–1187 (2011). https://doi.org/10.1007/s00204-011-0659-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-011-0659-4

Keywords

Search

Navigation